Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 39.05
+0.58 (1.51%)
Oct 23, 2026, 2:45 PM CST
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 10.31 billion as of October 22, 2026. It is the 8,201st most valuable company in the world and the 1,622nd biggest in China. Its market cap has decreased by 41.50% in one year.
Market Cap
10.31B
Enterprise Value
10.24B
Revenue
1.64B
Global Rank
Country Rank
#1,622 China
PE Ratio
63.25
ChartMarket Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 10.31B, an increase of 306.27%. That is a compound annual growth rate of 8.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 10.31B | -44.75% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 11.95B |
| Nanjing Vazyme Biotech | 11.53B |
| Hualan Biological Vaccine | 11.43B |
| Tibet Cheezheng Tibetan Medicine | 10.90B |
| Chengdu Olymvax Biopharmaceuticals | 10.82B |
| Shanghai Medicilon | 10.76B |
| Chengzhi | 9.87B |
| Staidson (Beijing) BioPharmaceuticals | 9.86B |